The Marburg virus, also known as the “bleeding eye” virus, has spread to multiple countries, prompting global concern over its deadly nature. The disease is typically transmitted through contact with infected individuals or Egyptian rousette bats.
According to the World Health Organization (WHO), 66 illnesses and 15 deaths have been reported in Rwanda, but many more cases may be infected. The average mortality rate of Marburg virus disease (MVD) is around 50%, although this has varied in different outbreaks from 24% to 88%.
Symptoms typically appear within 2-21 days after exposure and last for several weeks. The disease can have three phases: an initial “Generalization Phase” characterized by flu-like symptoms, followed by an “Early Organ Phase” with manifestations in specific organs like encephalitis or hemorrhages, and a final “Late Organ/Convalescence Phase” marked by multi-organ failure, shock, coma, and death.
In India, there is currently no data on Marburg virus cases. However, the Indian government has issued alerts for citizens traveling to affected areas. The medical community recommends avoiding contact with infected individuals, surfaces, or materials contaminated with bodily fluids, as well as practicing proper hygiene.
While there is no specific antiviral treatment available, early supportive care can improve survival chances. Treatment typically involves symptomatic relief, such as intravenous drug infusions and blood transfusions. Researchers are working on a vaccine, but human trials are ongoing.
It’s essential to note that not every person infected with Marburg virus dies. With timely diagnosis and treatment, the disease can be managed, and there have been cases of recovery. Isolation, contact tracing, and supportive care like rehydration and symptom management are critical in controlling the spread of the virus.
Source: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/bleeding-eye-disease-caused-by-marbug-virus-with-50-pc-survival-rate-a-cause-of-concern-spreads-through-human-contact-full-report/articleshow/115955444.cms